n (%) | |
---|---|
Age (years)a | 48.85 ± 11.49 |
Age groups (years) | |
≤ 30 | 5 (3.3) |
31–50 | 84 (56) |
> 50 | 61 (40.7) |
Tumor size (unit)a | 4.01 ± 1.99 |
Tumor stage | |
T1 | 26 (17.3) |
T2 | 79 (52.7) |
T3/T4 | 45 (30) |
Ki67 index (%) | 46.89 ± 23.88 |
ki67 index groups (%) | |
≤ 15 | 17 (11.3) |
16–24 | 8 (5.3) |
25–44 | 45 (30) |
> 44 | 80 (53.3) |
Nodal status | |
Positive | 64 (42.7) |
Negative | 86 (57.3) |
Nodal stage | |
No | 88 (58.7) |
N1 | 30 (20) |
N2 | 13 (8.7) |
N3 | 19 (12.7) |
Histological subtypes | |
IDC | 127 (84.7) |
Papillary | 6 (4) |
Medullary | 1 (0.7) |
Metaplastic | 14 (9.3) |
Mixed | 2 (1.3) |
Tumor grade | |
Grade-I | 1 (0.7) |
Grade-II | 19 (12.7) |
Grade-III | 130 (86.7) |
Lymphocytic infiltration | |
Absent | 15 (10) |
Moderate | 110 (73.3) |
Severe | 25 (16.7) |
Lymphovascular invasion | |
Present | 36 (24) |
Absent | 114 (76) |
Dermal lymphatic invasion | |
Present | 10 (6.7) |
Absent | 140 (93.3) |
Type of surgery | |
Modified radical mastectomy | 94 (62.7) |
Simple mastectomy with sentinel lymph node dissection | 42 (28) |
Wide local excision | 14 (9.3) |
Necrosis | |
Absent | 21 (14) |
Moderate | 90 (60) |
Severe | 39 (26) |
Fibrosis | |
Mild | 42 (28) |
Moderate | 88 (58.7) |
Severe | 20 (13.3) |
Insitu component | |
Present | 58 (38.7) |
Absent | 92 (61.3) |
Pagetoid spread | |
Present | 2 (1.3) |
Absent | 148 (98.7) |
Perinodal extension | |
Present | 30 (20) |
Absent | 120 (80) |
Adjuvant chemotherapy (n = 101) | |
Yes | 98 (97) |
No | 3 (3) |
Adjuvant radiotherapy (n = 101) | |
Yes | 69 (68.3) |
No | 32 (31.7) |
Reoccurrence (n = 101) | |
Yes | 18 (17.8) |
No | 83 (82.2) |